Has the survival of the heart failure population changed? Lessons from trials.
about
Consultation with cardiologists for persons with new-onset chronic heart failure: a population-based studyIncidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom.Effect of a medication-taking behavior feedback theory-based intervention on outcomes in patients with heart failure.Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction.Carvedilol in the treatment of elderly patients with chronic heart failure.Predictors of medication adherence using a multidimensional adherence model in patients with heart failure.Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure.Factors related to time to admission to specialized multidisciplinary clinics in patients with congestive heart failure.An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors.Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.Prognostic value of pulsed tissue Doppler imaging for the assessment of left ventricular systolic function in patients with nonischemic dilated cardiomyopathy.Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival.Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.Histopathological findings in skeletal muscle used in human dynamic cardiomyoplasty
P2860
Q33595903-6FE75875-F5C3-4846-8FE9-AB1B0B53CE51Q34395504-E96AE63F-702C-42CD-A27A-4946CC46310CQ35634575-C057F10A-DDAD-4BA2-B4F5-46A40AAF2E4AQ35770870-BE215E21-07A3-4DC1-9373-1EE0C6A49E3EQ36892905-1B5EF58D-DB71-4D57-8359-F1BE337E7B14Q37016847-56855A51-2309-4FBF-AE2C-1B187B75C92EQ37362262-B6970AD8-0F90-44AC-A872-10043D37D7AFQ37435176-1427EA0F-77CE-4E49-9F57-56D53A793B03Q39697622-E8698323-8D8E-4DB6-A9BE-C6B436651A33Q43711828-E7436A10-8D4F-40E6-8250-8EB110F72780Q44774765-5C813CD9-067F-4F43-9512-CF5C70D2E33CQ50770493-37E434CD-AA5E-4448-A801-F7EB547FFFB6Q53515461-E9C38CC3-AD6F-4744-B44E-E3D177F4E506Q58853944-2608260C-C08A-42C2-A3ED-44ACC8B6801E
P2860
Has the survival of the heart failure population changed? Lessons from trials.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Has the survival of the heart failure population changed? Lessons from trials.
@ast
Has the survival of the heart failure population changed? Lessons from trials.
@en
Has the survival of the heart failure population changed? Lessons from trials.
@nl
type
label
Has the survival of the heart failure population changed? Lessons from trials.
@ast
Has the survival of the heart failure population changed? Lessons from trials.
@en
Has the survival of the heart failure population changed? Lessons from trials.
@nl
prefLabel
Has the survival of the heart failure population changed? Lessons from trials.
@ast
Has the survival of the heart failure population changed? Lessons from trials.
@en
Has the survival of the heart failure population changed? Lessons from trials.
@nl
P1476
Has the survival of the heart failure population changed? Lessons from trials.
@en
P2093
P304
P356
10.1016/S0002-9149(98)01011-X
P407
P577
1999-03-01T00:00:00Z